Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Head: Sidebar: BOTOX CDH Study Group
Authors and Disclosures
Print This
Abstract and Introduction
Methods
Results
Comments
References
Sidebar: BOTOX CDH Study Group
Sidebar: BOTOX CDH Study Group
Andrew Blumenfeld, MD (California); Jan Lewis Brandes, MD (Tennessee);
Keith R. Edwards, MD (Vermont); Hmmmmmmm??????
Arthur Elkind, MD (New York); Brian Freund, MD (Ontario); Benjamin Frishberg, MD (California); Marek Gawel, MD (Ontario); Ninan Mathew, MD (Texas); Alexander Mauskop, MD (New York);
Peter McAllister, MD (Connecticut); Hmmmmmmmm?????
B. Todd Troost, MD (North Carolina); Bradley Wrubel, MD (California); Rozalina Dimitrova MD, MPH (California); John Gibson, MD (California); Pan Yu Lai, PhD (California); Catherine Turkel, PharmD, MBA (California).
« Return to: Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double-Blind, Placebo-Controlled Study
Authors and Disclosures
Print This
Abstract and Introduction
Methods
Results
Comments
References
Sidebar: BOTOX CDH Study Group
Sidebar: BOTOX CDH Study Group
Andrew Blumenfeld, MD (California); Jan Lewis Brandes, MD (Tennessee);
Keith R. Edwards, MD (Vermont); Hmmmmmmm??????
Arthur Elkind, MD (New York); Brian Freund, MD (Ontario); Benjamin Frishberg, MD (California); Marek Gawel, MD (Ontario); Ninan Mathew, MD (Texas); Alexander Mauskop, MD (New York);
Peter McAllister, MD (Connecticut); Hmmmmmmmm?????
B. Todd Troost, MD (North Carolina); Bradley Wrubel, MD (California); Rozalina Dimitrova MD, MPH (California); John Gibson, MD (California); Pan Yu Lai, PhD (California); Catherine Turkel, PharmD, MBA (California).
« Return to: Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double-Blind, Placebo-Controlled Study